21st Annual Abracadabra Diabetes Nursing Conference | Diabetes on the Net

Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

This promotional virtual conference has been developed, organised and funded by Lilly in conjunction with the Abracadabra Programme Planning Committee. Lilly Products will be discussed at these meetings, and prescribing information will be available during the conference. Lilly is a registered trademark of Eli Lilly and Company. © 2021 Eli Lilly and Company. All rights reserved.

Prescribing information for Lilly products can be accessed at the following links: Abasaglar® (insulin glargine)Humalog® (insulin glargine)Lyumjev® (insulin lispro) (Please note: Lyumjev is not available in the ROI), Trulicity® (dulaglutide). For more information about Lilly products please visit www.lillydiabetes.co.uk (UK only).

Taking place on:

Next event starting shortly. Already registered?

Fast forward

21st Annual Abracadabra Diabetes Nursing Conference

For diabetes, 2021 is a genuine milestone as it represents the 100‑year anniversary of the discovery of insulin, which was a game-changer for diabetes therapy. The same spirit of innovation endures today as the management of diabetes continues to advance in the modern age.

The 21st Annual Abracadabra Diabetes Nursing Conference will this year seek to capture that same ‘spirit’ and present a range of topics that celebrate achievement and present a view towards a bright future for effective diabetes therapies and empowering patient care

What does the programme offer?

Upcoming events

Celebrating 100 years and 21st century diabetes

Insulin was discovered 100 years ago and provided the first effective therapy for diabetes. Innovation has continued and modern technology provides more and more support for diabetes care. This session will look at both the past and the future, and explores what technology and improvements in communications can offer in the struggle against diabetes.

This webinar includes a choice of 2 breakout sessions. On the day of the meeting, you will be able to choose which breakout you would like to attend.

Introduction and welcome

• Welcome, introduction to the meeting series and instructions for delegates
• Introduction to the theme of webinar 1 and agenda

100 years of insulin – from Banting to bolus

• Looking back at the last 100 years of treating diabetes
• Looking at current treatments and technology
• Looking forward: What does the future look like for people living with diabetes?

Live Q&A

Breakout 1: Maximising the benefits from recent advances in diabetes technology

Advances in glucose monitoring: Continuous glucose monitoring and flash monitoring options
• Insulin pumps – options available, guidance on their use and patient education advice
• Selecting the right technology for the individual patient – when to offer a hybrid closed loop
• Live Q&A

Live Q&A

Breakout 2: Diabetes communication in the 21st century

• The impact of language: how the words we use can affect the care we provide
• Communication within the multidisciplinary team
• What is good or effective communication?
• Live Q&A

Live Q&A

Impact of cardio-renal-metabolic comorbidities in people living with type 2 diabetes

Cardiovascular and renal risk along with good glycaemic control are foremost in the considerations for long-term treatment of diabetes. This session will discuss care in patients with cardiovascular and renal risk factors.

This webinar includes a choice of 2 breakout sessions. On the day of the meeting, you will be able to choose which breakout you would like to attend.

Introduction and welcome

• Welcome, introduction and instructions for delegates
• Introduction to the theme of webinar 2 and agenda

Managing cardiovascular risk in adults with type 2 diabetes and the multifactorial role of Trulicity (dulaglutide)

• The burden of cardiovascular disease in adults with type 2 diabetes and the broad cardiovascular prevention strategy
• Diabetes guidelines and the role of GLP-1RAs in the treatment pathway
• Trulicity (dulaglutide) data and how this can support patients with and without cardiovascular disease

Live Q&A

Breakout 1: Diabetic kidney disease: challenges and opportunities

• The significantly increasing burden of kidney complications in diabetes
• Clinical management of the person identified as having kidney disease in the context of diabetes
• Preventing kidney complications of diabetes by connecting the medical model with strategies to engage the individual with diabetes
• Live Q&A

Live Q&A

Breakout 2: Too high, too low: the consequences of suboptimal glycaemic control

• Identifying the microvascular complications of diabetes
• Glycaemic variability and quality of life
• Identification and prevention of hypoglycaemia
• Live Q&A

Live Q&A

Supported self-management: Empowering people with diabetes - UK participants

Technology is now providing people with diabetes the ability to take control and improve their time in range. At the same time diabetes can still be a debilitating condition and diabetes nurses are still there for those who need their expertise. This session will look at ways to support self-management and the similarities between the psychology of diabetes for the people living with the condition and the nurses treating them. It will also examine how to best help those who are experiencing diabetes during pregnancy.

Introduction and welcome

• Welcome, introduction and instructions for delegates
• Introduction to the theme of webinar 3 and agenda

The challenges of post-prandial hyperglycaemia: strategies and insights

• How post-prandial glucose contributes to overall time in range
• Finding a therapeutic management option that suits the individual’s lifestyle
• Case studies: How improving post-prandial glucose control can engage and empower people living with diabetes

Live Q&A

Why is being a Diabetes Specialist Nurse like being a person with diabetes?

• Psychological impact of living with diabetes
• Dealing with work-related stress in diabetes nursing
• Psychological challenges that are common to both DSNs and people with diabetes
• Live Q&A

Live Q&A

Pregnancy planning, gestational diabetes and post-pregnancy support: A perspective from the clinic

• Minimising the risks of pre‑existing diabetes during pregnancy
• The implications of poor control of diabetes during pregnancy, and how diabetes care can be optimised at this time
• Gestational diabetes: diagnosis, management and the impact on the patient during pregnancy and beyond
• Live Q&A

Live Q&A

Supported self-management: Empowering people with diabetes - Republic of Ireland participants

For people with diabetes the importance of regular reviews and the availability of advice from diabetes nurses and other professionals has never been so important. In this Ireland-specific session, we will examine how diabetes awareness has been improved across the country by the introduction of new policies and education programmes, as well as looking at the importance of regular foot examinations and the challenges posed by diabetes during pregnancy.

Introduction and welcome

• Welcome, introduction and instructions for delegates
• Introduction to the theme of webinar 3 and agenda

2010 to 2020, Standing on the Shoulders of Giants

• Overview of the multiple class of agents available at the start of the decade
• 2012 EASD/ADA algorithm
• Evolution of the clinical care programme
• 2018 EASD/ADA algorithm
• Evolution of the model of care and how current treatment options empower patients, improve patient outcomes and futures

Live Q&A

A guide to caring for feet in people with diabetes

• The importance of early diagnosis for foot problems
• Remote management of foot issues
• Treating vulnerable patients
• Case presentations on referral pathways – where we could have done better
• Live Q&A

Live Q&A

Before, during and after pregnancy with pre-existing diabetes: A Registered Advanced Midwife Practitioner (RAMP) Diabetes perspective

• Minimising the risks of pre‑existing diabetes during pregnancy
• The implications of poor control of diabetes during pregnancy, and how diabetes care can be optimised at this time
• Challenges of managing diabetes in pregnancy
• Live Q&A

Live Q&A

Speakers

Mark-Davies.jpg

Dr Mark Davies

Consultant Clinical Psychologist, Belfast Health and Social Care Trust, Northern Ireland

Jane-Diggle.jpg

Jane Diggle

Practice Nurse with Specialist Interest in Diabetes, West Yorkshire

Su-Down.jpg

Su Down

Diabetes Nurse Consultant, Somerset

Dr-Kevin-Fernando.jpg

Dr Kevin Fernando

GP, North Berwick, near Edinburgh

Dr-Andrew-Frankel.jpg

Dr Andrew Frankel

Consultant Nephrologist, Imperial College Healthcare NHS trust, London

Dorothy Frizelle

Dr Dorothy Frizelle

Consultant Clinical Health Psychologist, University of Hull

Leona-Guinan.jpg

Leona Guinan

Clinical Nurse Specialist in Diabetes, South Tipperary General Hospital

Dr-Kunal-Gulati.jpg

Kunal Gulati

Senior Medical Lead - Lilly Diabetes

Peter Hammond (2)

Dr Peter Hammond

Consultant Endocrinologist – Harrogate and District NHS Foundation

Dr-Yassir-Javaid.jpg

Dr Yassir Javaid

GPwSI in Cardiology, Northampton

Professor-Partha-Kar.jpg

Professor Partha Kar

Consultant Diabetologist, Portsmouth

Nicola-Milne_1.jpg

Nicola Milne

Community Diabetes Specialist Nurse, Manchester

Yvonne Moloney

Yvonne Moloney

Registered Advanced Midwife Practitioner Diabetes, University of Limerick Hospitals Group, Republic of Ireland

Matthew Murphy (2)

Dr Matthew Murphy

Consultant Endocrinologist , South Infirmary Hospital, Cork, Republic of Ireland

David Watterson​

David Watterson

Podiatry Clinical Manager of CHO Area 2, Galway, Republic of Ireland

Dr-Emma-Wilmot_01.jpg

Dr Emma Wilmot

Consultant Diabetologist, University Hospitals Derby; Assistant Professor, University of Nottingham

Dr-Matthew-Murphy.jpg

Dr Matthew Murphy

Consultant Endocrinologist , South Infirmary Hospital, Cork, Republic of Ireland

David-Watterson.jpg

David Watterson

Podiatry Clinical Manager of CHO Area 2, Galway, Republic of Ireland

21st Annual Abracadabra

Diabetes Nursing Conference

Taking place on:

This promotional virtual conference has been developed, organised and funded by Lilly in conjunction with the Abracadabra Programme Planning Committee. Lilly Products will be discussed at these meetings, and prescribing information will be available during the conference. Lilly is a registered trademark of Eli Lilly and Company. © 2021 Eli Lilly and Company. All rights reserved.

Prescribing information for Lilly products can be accessed at the following links: Abasaglar® (insulin glargine)Humalog® (insulin glargine)Lyumjev® (insulin lispro) (Please note: Lyumjev is not available in the ROI), Trulicity® (dulaglutide). For more information about Lilly products please visit www.lillydiabetes.co.uk (UK only).

Adverse events and product complaints should be reported. Reporting forms and further information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store (UK) or www.hpra.ie (ROI). Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on +44 (0) 1256 315000 or Lilly Ireland on +353 (0)1 664 0446 (ROI).

PP-LD-GB-1047 | March 2021

21st Annual Abracadabra Diabetes Nursing Conference

This website is for healthcare professionals

This website is for UK and ROI healthcare professionals only. To continue, please confirm that you are a UK or ROI healthcare professional by clicking the ‘Confirm’ button below.

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.